Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease

Clin Infect Dis. 1996 Dec;23(6):1321-2. doi: 10.1093/clinids/23.6.1321.

Authors

D E Griffith¹, B A Brown, R J Wallace Jr

Affiliation

¹ Department of Medicine, University of Texas Health Center, Tyler 75710, USA.

PMID: 8953085
DOI: 10.1093/clinids/23.6.1321

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Azithromycin / therapeutic use
Clarithromycin / therapeutic use
Dose-Response Relationship, Drug
Drug Therapy, Combination
HIV
Humans
Leukocyte Count / drug effects*
Lung Diseases / drug therapy
Mycobacterium avium Complex*
Mycobacterium avium-intracellulare Infection / drug therapy*
Platelet Count / drug effects*
Rifabutin / therapeutic use*

Substances

Rifabutin
Azithromycin
Clarithromycin